Introduction What does it take to create and nurture life science innovation and why is it important? No doubt, this is a broad and deep topic, and would not be adequately addressed in a single white paper. As a result,...
As has been thoroughly discussed by this author and others, the so-called “valley of death” is a critical barrier for the advancement of life science (therapeutic, vaccine, medical device, diagnostic and related)...
Aurora, CO - Neurexis Therapeutics, a leading biopharmaceutical company focused on developing neuroprotective interventions, has been awarded a prestigious $3 million Phase II Small Business Innovation Research (SBIR)...
Both universities and regional entities have become more active in providing critically needed support to faculty innovators with commercially relevant technologies.
This NIAID SBIR will evaluate an innovative approach for producing superior vaccines more quickly and cost-effectively. FORT COLLINS, CO – Solaris Vaccines, Inc. announced today that it has received a Small Business...
A promising approach for preventing cognitive and behavioral impairment following ischemia Aurora, CO - Neurexis Therapeutics, Incorporated, announces it has been awarded $900,000 in funding from a Direct-to-Phase II...
FORT COLLINS, CO – Solaris Vaccines, Inc. announced today that Dr. Izabela Ragan (DVM, PhD), an expert in novel vaccine technologies, has joined as Director of Research and Development. The Company is developing a...
I have been very fortunate to have had a varied and diverse career accelerating the development of life science innovation, including therapeutics, vaccines, medical devices, diagnostics, analytical instruments,...
In Part 1 of this series, I touched on some of the unique considerations for advancing early-stage innovation beyond the academic setting. For this article, I’d like to dig deeper into the topic of university...
The honest truth? Deciding which early-stage technologies will be successful is really hard. This is even more the case when you add the challenges faced in a university setting. Although I’m currently on the investment...
FEATURED RESOURCES
